PERFIL EPIDEMIOLÓGICO E PREVALÊNCIA DAS ALTERAÇÕES CITOPATOLÓGICAS DO COLO DO ÚTERO NO TOCANTINS DE 2019 A 2023

• DOI: https://doi.org/10.22533/at.ed.5642417058

• Palavras-chave: Teste de Papanicolau. Displasia do colo uterino. Neoplasia epitelial intracervical. Perfil epidemiológico.

• Keywords: Pap smear test. Cervical dysplasia. Intracervical epithelial neoplasia. Epidemiological profile.

• Abstract: The uterus is a fibromuscular organ that can be divided into body, fundus, isthmus and cervix. This last portion has an area where cellular transformation processes physiologically occur - the Transformation Zone, for which the HPV virus has greater tropism and whose persistent infection is the main factor associated with cervical cancer. This neoplasm is the third most common among Brazilian women and can be tracked by Oncotic Colpocytology, Pap smears or cervical cancer prevention (PCCU). This study proposes a cross-sectional, quantitative and descriptive analysis of the epidemiological profile and prevalence of cytopathological changes in the cervix in Tocantins between 2019 and 2023, based on data collected by the Cancer Information System on the Tabnet platform - DATASUS of the Ministry of Health. obtained will be tabulated in spreadsheets using the Microsoft Excel program. In Tocantins, between 2019 and 2023, 184,149 PCCUs were performed, and 86% showed benign changes or changes related to the effect of HPV. The main year was 2023 - 45,198 exams. During this period, 95% of those collected were satisfactory and 59% were representative of the ZT. Regarding HPV-induced dysplasias, the most prevalent change was ASC-US - 2,869 samples (29.84% of the total), and the most affected age group was 30 to 39 years old - 1,384 cases (14.9% of the total) . The municipality with the most samples was Palmas - 31,637, of which 28% were ASC-H. Carrying out the PCCU depends on human execution, and the high percentage of inadequate collections and information ignored in the exam record are factors still present in Tocantins that negatively impact the database supply. The assessment of morbidity indicators is crucial to measuring the magnitude of the disease and, thus, planning health actions, directing resources and training professionals.